Recent Patents On Anti-cancer Drug Discovery

雜志介紹

Recent Patents On Anti-cancer Drug Discovery雜志介紹

《Recent Patents On Anti-cancer Drug Discovery》是一本以English為主的未開放獲取國際優秀期刊，中文名稱最近的抗癌藥物發現專利，本刊主要出版、報道醫學-ONCOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.5，最新CiteScore 指數為4.5。

本刊近期中國學者發表的論文主要有：

• High-throughput Strategy Accelerates the Progress of Marine Anticancer Peptide Drug Development.

  Author: Lyu P¹, Kwok HF¹.

• Chimeric Antigen Receptor T Cell Immunotherapy for Tumor: A Review of Patent Literatures

  Author: Fu M¹, Tang L¹.

• From Antimicrobial to Anticancer Peptides: The Transformation of Peptides.

  Author: Qin Y^1,2, Qin ZD¹, Chen J³, Cai CG⁴, Li L¹, Feng LY¹, Wang Z¹, Duns GJ¹, He NY², Chen ZS⁵, Luo XF¹.

• Enzyme and Transporter Kinetics for CPT-11 (Irinotecan) and SN-38: An Insight on Tumor Tissue Compartment Pharmacokinetics Using PBPK.

  Author: Fan Y^1,2, Mansoor N³, Ahmad T⁴, Wu ZX², Khan RA³, Czejka M⁵, Sharib S⁴, Ahmed M⁶, Chen ZS², Yang DH².

英文介紹

Recent Patents On Anti-cancer Drug Discovery雜志英文介紹

Aims & Scope

Recent Patents on Anti-Cancer Drug Discovery publishes review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.